Search Site

Zilico Limited

Zilico News

Keep up to date with the latest news and press releases from Zilico.

  • 51 to 60 of 76
  • 1
  • 2
  • 3
  • 8
  • Zilico named as finalists at Excellence in Supply Awards

    Oct '14 2

    Zilico Ltd has been named a finalist in the ‘Innovation – Clinical’ category at the North West Excellence in Supply Awards 2014.
    more details ]
  • ZedScan to be presented at Swedish Society of Obstetrics and Gynaecology meeting

    Sep '14 23

    Zilico Ltd has been invited to present its pioneering CE marked cervical cancer diagnostics system – ZedScan – at the Swedish Society of Obstetric and Gynaecology (SFOG) colposcopy meeting later this month.
    more details ]
  • Zilico receives backing for development of oral cancer diagnostic

    Jul '14 21

    Zilico Ltd has begun development work on a medical device which uses Electrical Impedance Spectroscopy (EIS) in the detection and diagnosis of oral cancer following funding from the Technology Strategy Board, the UK’s innovation agency.   The two awards are from the Biomedical Catalyst Feasibility and Smart Funds. The funds will help support an in-depth analysis of the UK market, deliver a product specification for an oral diagnostic device and a protocol for a multi-centre trial.
    more details ]
  • Zilico at IFCPC, 2014

    Jun '14 20

    Zilico Ltd recently exhibited at the 15th World Congress for Cervical Pathology and Colposcopy from the International Federation for Cervical Pathology and Colposcopy (IFCPC 2014) in London. Zilico presented its innovative diagnostic device, ZedScan, discussing its clinical and economic benefits to some of the world’s leading clinicians from the field of Colposcopy and Cervical Pathology with support from four of its distributors from Thailand, Israel, Ireland and UK.
    more details ]
  • ZedScan presented to international cervical pathology and colposcopy meeting

    May '14 20

    Zilico Ltd is set to present its innovative cervical cancer diagnostic system ZedScan™ to the foremost international meeting of cervical pathology and colposcopy clinicians for the first time since its CE Mark approval. ZedScan will be exhibited at the 15 th World Congress for Cervical Pathology and Colposcopy from the International Federation for Cervical Pathology and Colposcopy (IFCPC 2014) in London (26-30 May 2014). 
    more details ]
  • Zilico makes moves in the Australian Market

    Apr '14 15

    Zilico Ltd has made two major announcements which will see the company’s cervical cancer diagnostics product – ZedScan  I  – start being sold in to the Australian healthcare market. ZedScan  I  has obtained approval from Therapeutic Goods Administration (TGA) - the regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia.
    more details ]
  • Zilico receives national award for its work with the NHS

    Apr '14 3

    Zilico Ltd has received national recognition for its work with the NHS by winning a prestigious Medilink UK Healthcare Business Award. Zilico won the ‘Partnership with the NHS Award’ at the national event which was held at the end of the first day of the Med-Tech Innovation Expo, at the Ricoh Arena, Coventry. The award is presented to a company that has developed collaborations with the NHS and will have a major impact on business performance or patient care. The award was accepted by Zilico’s Technical Director, Peter Highfield.
    more details ]
  • Zilico wins Medilink Yorkshire & Humber Award

    Mar '14 20

    Zilico honoured for its work with NHS Cervical cancer diagnostics company Zilico Ltd has won a major award for its work with the NHS. Zilico won the Medilink Yorkshire and Humber Healthcare Business Award for ‘Partnership with the NHS’ at a prestigious ceremony held at the Royal Armouries, Leeds. Zilico won the award for the team’s development of the company’s revolutionary cervical cancer diagnostic system Zedscan  The system which recently received EC certification from its notified body, is used alongside colposcopy on women identified with an abnormal smear result, offering more accurate detection of cervical neoplasia in real-time.
    more details ]
  • Zilico raises money for Jo's Cervical Cancer Trust

    Mar '14 3

    Manchester-based Zilico Ltd has raised more than £600 for Jo’s Cervical Cancer Trust, a national charity dedicated to women with cervical cancer.  
    more details ]
  • Zedscan to be showcased at Arab Health 2014

    Jan '14 9

    Zilico Ltd will present its pioneering CE marked cervical cancer diagnostic system at Arab Health 2014. The British company’s innovative system, ZedScan I, which received EC certification from its notified body in September, 2013, offers more accurate detection of cervical neoplasia in real-time, enabling clinicians to improve patient management.
    more details ]